Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) have received a …
Ligand Pharmaceuticals Incorporated (LGND) traded on unusually high volume on Aug. 17, as the stock lost 0.72% to close at $126.62. On the day, Ligand Pharmaceuticals Incorporated saw 332,255 shares trade hands on 2,245 trades. …
Ligand Pharmaceuticals Incorporated (LGND - Free Report) reported second-quarter 2017 earnings of 54 cents per share (including the after-tax impact of stock-based compensation expenses), significantly up 157.1% from the year-ago …
SmarTrend identified an Uptrend for Ligand Pharm (NASDAQ:LGND) on March 10th, 2017 at $108.63. In approximately 5 months, Ligand Pharm has returned 16.88% as of today's recent price of $126.97. Over the past year, Ligand Pharm …
Disclosure: I am/we are long LGND. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is …
Follow Ligand on Twitter @Ligand_LGND. Forward-Looking Statements This news release contains ... The failure to …
Ligand Pharmaceuticals Inc. (LGND) reported second quarter EPS of $0.67 after the bell Monday, up from $0.35 in the prior year period. Ligand Pharmaceuticals gapped open higher Tuesday and spiked to the upside in early trade. The …
Claus Moller decreased its stake in Ebix Inc (EBIX) by 0.9% based on its latest 2016Q4 regulatory filing with the SEC. The hedge fund run by Claus Moller held 1.62M shares of the technology company at the end of 2016Q4, valued at $92.42 …
The stock spiked 7.8% last month and is up 24.96 this year. They expect $1.42 earnings per share, up 1.43% or $0.02 from last year's $1.4 per share. Ligand Pharmaceuticals now has $2.61 billion valuation. Ligand Pharmaceuticals …
Tocqueville Asset Management Lp acquired 5,786 shares as Ligand Pharmaceuticals Inc Cl (LGND)’s stock rose …